Ingevity Corp (NGVT) stock
NGVTNYSEChemicals & Allied ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30134% above fair value
$53.75−2.21 (-3.95%)
Close on Nov 20, 2026Market cap $1.85BP/E 36.6Yield –
Ingevity free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Ingevity's free cash flow for the twelve months ending Jun 30, 2026 was $154.90M, up 3.1% year over year. For fiscal 2025 it was $273.50M, up 436.3% from the year before. The highest annual figure on record is $273.50M in fiscal 2025.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $273.50M | +436.3% |
| FY2024 | Dec 31, 2024 | $51.00M | -46.5% |
| FY2023 | Dec 31, 2023 | $95.30M | -44.2% |
| FY2022 | Dec 31, 2022 | $170.90M | -9.8% |
| FY2021 | Dec 31, 2021 | $189.50M | -29.9% |
| FY2020 | Dec 31, 2020 | $270.30M | +68.0% |
| FY2019 | Dec 31, 2019 | $160.90M | +1.8% |
| FY2018 | Dec 31, 2018 | $158.10M | +29.9% |
| FY2017 | Dec 31, 2017 | $121.70M | +70.9% |
| FY2016 | Dec 31, 2016 | $71.20M | – |
| FY2015 | Dec 31, 2015 | -$28.70M | -178.2% |
| FY2014 | Dec 31, 2014 | $36.70M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$24.10M | -136.1% |
| Q1 FY2026 | Mar 31, 2026 | -$12.30M | -179.9% |
| Q4 FY2025 | Dec 31, 2025 | $73.50M | +85.6% |
| Q3 FY2025 | Sep 30, 2025 | $117.80M | +313.3% |
| Q2 FY2025 | Jun 30, 2025 | $66.80M | +475.9% |
| Q1 FY2025 | Mar 31, 2025 | $15.40M | – |
| Q4 FY2024 | Dec 31, 2024 | $39.60M | +132.9% |
| Q3 FY2024 | Sep 30, 2024 | $28.50M | -60.3% |
| Q2 FY2024 | Jun 30, 2024 | $11.60M | -56.6% |
| Q1 FY2024 | Mar 31, 2024 | -$28.70M | – |
| Q4 FY2023 | Dec 31, 2023 | $17.00M | -65.5% |
| Q3 FY2023 | Sep 30, 2023 | $71.70M | +12.0% |
| Q2 FY2023 | Jun 30, 2023 | $26.70M | -56.2% |
| Q1 FY2023 | Mar 31, 2023 | -$20.10M | – |
| Q4 FY2022 | Dec 31, 2022 | $49.30M | +26.7% |
| Q3 FY2022 | Sep 30, 2022 | $64.00M | -14.2% |
| Q2 FY2022 | Jun 30, 2022 | $60.90M | +45.3% |
| Q1 FY2022 | Mar 31, 2022 | -$3.30M | -109.7% |
| Q4 FY2021 | Dec 31, 2021 | $38.90M | -68.2% |
| Q3 FY2021 | Sep 30, 2021 | $74.60M | +1.5% |
| Q2 FY2021 | Jun 30, 2021 | $41.90M | +23.6% |
| Q1 FY2021 | Mar 31, 2021 | $34.10M | -16.2% |
| Q4 FY2020 | Dec 31, 2020 | $122.20M | +142.0% |
| Q3 FY2020 | Sep 30, 2020 | $73.50M | -23.9% |
| Q2 FY2020 | Jun 30, 2020 | $33.90M | -32.1% |
| Q1 FY2020 | Mar 31, 2020 | $40.70M | – |
| Q4 FY2019 | Dec 31, 2019 | $50.50M | +4.6% |
| Q3 FY2019 | Sep 30, 2019 | $96.60M | +39.8% |
| Q2 FY2019 | Jun 30, 2019 | $49.90M | +12.6% |
| Q1 FY2019 | Mar 31, 2019 | -$36.10M | – |
| Q4 FY2018 | Dec 31, 2018 | $48.30M | +98.8% |
| Q3 FY2018 | Sep 30, 2018 | $69.10M | +3.9% |
| Q2 FY2018 | Jun 30, 2018 | $44.30M | +26.2% |
| Q1 FY2018 | Mar 31, 2018 | -$3.60M | – |
| Q4 FY2017 | Dec 31, 2017 | $24.30M | -29.4% |
| Q3 FY2017 | Sep 30, 2017 | $66.50M | +191.7% |
| Q2 FY2017 | Jun 30, 2017 | $35.10M | – |
| Q1 FY2017 | Mar 31, 2017 | -$4.20M | – |
| Q4 FY2016 | Dec 31, 2016 | $34.40M | – |
| Q3 FY2016 | Sep 30, 2016 | $22.80M | – |
See a number that looks wrong?